Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Injection in Non-diabetic Overweight or Obese Adult Subjects
Clinical trial NCT06714955 · COMPLETED
Trial details
- NCT number
- NCT06714955
- Sponsor
- BrightGene Bio-Medical Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-21
- Primary completion
- 2025-01-21
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.